SNPs in MicroRNA Binding Sites as Prognostic and Predictive Cancer Biomarkers
- 1 January 2013
- journal article
- review article
- Published by Begell House Inc. Publishers in Critical Reviews™ in Oncogenesis
- Vol. 18 (4) , 327-340
Abstract
Single-nucleotide polymorphisms within microRNA (miRNA) binding sites comprise a novel genre of cancer biomarkers. Since miRNA regulation is dependent on sequence complementarity between the mRNA transcript and the miRNA, even single-nucleotide aberrations can have significant effects. Over the past few years, many examples of these functional miRNA binding site SNPs have been identified as cancer biomarkers. While most of the research to date focuses on associations with cancer risk, more and more studies are linking these SNPs to cancer prognosis and response to treatment as well. This review summarizes the state of the field and draws importance to this rapidly expanding area of cancer biomarkers.Keywords
This publication has 64 references indexed in Scilit:
- A MicroRNA-7 Binding Site Polymorphism in HOXB5 Leads to Differential Gene Expression in Bladder CancerPLOS ONE, 2012
- The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian CancerPLOS ONE, 2012
- A Let-7 MicroRNA SNP in the KRAS 3′UTR Is Prognostic in Early-Stage Colorectal CancerClinical Cancer Research, 2011
- A miR-200b/200c/429-Binding Site Polymorphism in the 3′ Untranslated Region of the AP-2α Gene Is Associated with Cisplatin ResistancePLOS ONE, 2011
- A functional polymorphism at microRNA-629-binding site in the 3′-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese populationCarcinogenesis, 2011
- C–T variant in a miRNA target site of BCL2 is associated with increased risk of human papilloma virus related cervical cancer—An in silico approachGenomics, 2011
- A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal womenCarcinogenesis, 2008
- Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic markerCarcinogenesis, 2008
- Thelet-7microRNA reduces tumor growth in mouse models of lung cancerCell Cycle, 2008
- Suppression of non-small cell lung tumor development by the let-7 microRNA familyProceedings of the National Academy of Sciences, 2008